BSE filing, NSE: VADILENT. Summary written from the filing by ALFA Finder's alert engine.
Vadilal Enterprises Ltd: key numbers
- Share price
- ₹9,370.00
- Market cap
- ₹808.4 Cr
- Revenue (annual)
- ₹1,217 Cr
- Net profit (annual)
- ₹10.45 Cr
- P/E (TTM)
- 59.2×Sector 38.6×
- Promoter holding
- 51.03%+0.00% QoQ
- FII holding
- 0.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vadilal Enterprises Ltd
All →Vadilal Enterprises Annual General Meeting
Vadilal Enterprises' EGM approved execution of a sale and purchase agreement with Vadilal Industries Limited. No transaction value was disclosed.
Vadilal Enterprises Board Meeting Date
Vadilal Enterprises Ltd intimated a Board meeting on October 30, 2026, to approve Q1 and H1 FY27 Ind AS results. Trading window remains closed until November 1.
Vadilal Enterprises Annual General Meeting
Vadilal Enterprises Limited has issued a notice for an Extra-Ordinary General Meeting scheduled for October 27, 2026. The meeting seeks shareholder approval for a supply agreement with Vadilal Industries Limited.
- Execution
- 12 months
Vadilal Enterprises Partnership
Vadilal Enterprises Ltd reached a fresh supply agreement with Vadilal Industries Limited valid until October 2027. The agreement ensures business continuity following previous shareholder rejection of a renewal.
- From
- Vadilal Industries Limited
- Execution
- Up to October 31, 2027
Vadilal Enterprises Board Meeting Outcome
Vadilal Enterprises Limited's board has approved convening an Extra Ordinary General Meeting on October 27, 2026. The meeting will be conducted via video conferencing with a record date of October 20, 2026.
Vadilal Enterprises Credit Rating
India Ratings and Research has downgraded Vadilal Enterprises Ltd's long-term bank loan rating to IND A- and short-term rating to IND A2+, with Negative Implications.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.